Monday, August 12, 2019

Session I: Neuronal Lipid Signaling

Session Chair: Russell DeBose-Boyd, PhD

7:30-8:15 AM Conference Check-In and Breakfast (Grand Ballroom Foyer Registration Desk)

8:15 AM Introduction and Presentation of the Kern Lectureship Award - Moshe Levi, MD, Georgetown University

8:25 AM Kern Lecture: “Lysophospholipid Signaling Pathways at the CNS- Immunology Interface” - Benjamin F. Cravatt III, PhD, Scripps Research Institute – USA

9:15 AM “Lipid Sensing from the Periphery to the CNS” - Gary Schwartz, PhD, Albert Einstein – USA

9:45 AM “Apolipoproteins in Neurodegenerative Disease” - Cheryl Wellington, PhD, The University of British Columbia – Canada

10:15 AM Coffee Break

10:30 AM “Hypothalamic Control of Energy Metabolism in Obesity” - Jens Brüning, PhD, Max Planck Institute for Metabolism Research – Germany

11:00 AM “Lipid Signaling in the Gut-Brain Axis” - Tony Lam, PhD, University of Toronto – Canada

11:30 AM “Title - To Be Determined - Selected From Abstracts” - Young Investigator Short Talk

12:00 AM Lunch (Mountain View Patio)

1:00-4:15 PM Afternoon Break

Session II: Neuronal Lipid Signaling

Session Chair: John Parks, PhD

4:15 PM Targeting Liver Lipid Metabolism with AMPK ActivatorsRussell Miller, PhD, Pfizer – USA

4:45 PM “New Therapeutics in Cardiometabolic Disease” - Laura Michael, PhD, Eli Lilly – USA

5:15 PM “Cardiovascular and Metabolic Effects of Lipoprotein (a) Antisense Oligonucleotides”” - Rosanne Crooke, PhD, IONIS Pharmaceuticals – USA

5:45 PM “Genome Editing Approaches in Lipid Metabolic Disturbances” - Kiran Musunuru, MD, PhD, MPH, University of Pennsylvania – USA

6:00 PM Poster Session (Grand Ballroom, Salons F-J)